MedPath

Development and evaluation of an internet-based psychological support program for parents caring for a child with CF

Not Applicable
Conditions
F41.1
F43
F41.2
Reaction to severe stress, and adjustment disorders
Generalized anxiety disorder
Mixed anxiety and depressive disorder
Registration Number
DRKS00004451
Lead Sponsor
niversitätsklinikum Ulm, Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
31
Inclusion Criteria

caregiver of a minor child (0-17 years) with a confirmed diagnosis of CF
- have a score = 8 points on the HADS Anxiety subscale
- have permanent access to a computer with internet connection
- be able to read and write fluent German

Exclusion Criteria

- acute suicidality
- psychotic symptoms
- concurrent psychotherapy
- change in psychotropic medication six weeks before the start of the treatment and during treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary endpoint is the reduction of anxious symptoms measured online with the Anxiety Subscale of the Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith) at baseline (before the intervention), after completion of the last treatment session and three month after completion of the intervention program.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints are the reduction of illness related fears (measured with an adapted version of the Fear of Progression Questionnaire, FoP-Q, Herschbach et al.), the reduction of depressive symptoms (Center for Epidemiological Studies Depression Scale CES, German Version: ADS-K, Hautzinger & Bailer), the improvement of the parents`quality of life (Ulm quality of life inventory for parents of chronically ill children, Goldbeck & Storck) and coping skills (Coping Health Inventory for Parents, CHIP, German Version, McCubbin & McCubbin). All questionnaires are administered online at baseline, after completion of the last treatment session and three month after completion of the intervention program. Additionally, the acceptance of the intervention is evaluated at the end of treatment. For this purpose a short questionnaire was developed.
© Copyright 2025. All Rights Reserved by MedPath